Kwong Lung Enterprise Co., Ltd. (TPEX: 8916)

Kwong Lung Enterprise Income Statement

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	7,556	7,708	10,304	8,061	8,499	10,594
Revenue Growth (YoY)	-11.63%	-25.19%	27.83%	-5.16%	-19.78%	4.33%
Cost of Revenue	6,254	6,326	8,541	7,072	7,327	9,155
Gross Profit	1,302	1,382	1,763	988.66	1,172	1,438
Selling, General & Admin	683.83	681.46	749.08	674.32	663.98	790.97
Research & Development	51.86	53.07	50.91	48.82	53.65	51.92
Operating Expenses	743.68	784.9	809.49	800.8	791.21	842.89
Operating Income	557.94	597.23	953.71	187.87	380.37	595.53
Interest Expense	-31.06	-25.34	-20.96	-13.92	-14.19	-28.28
Interest & Investment Income	58.53	61.24	37.61	23.12	21.05	21.69
Earnings From Equity Investments	-3.27	23.06	25.77	118.75	11.63	6.51
Currency Exchange Gain (Loss)	-62.78	28.37	207.3	-28.73	4.74	-2.96
Other Non Operating Income (Expenses)	72.25	63.14	-86.74	-8.17	22.13	19.81
EBT Excluding Unusual Items	591.62	747.71	1,117	278.91	425.73	612.3
Gain (Loss) on Sale of Investments	83.4	-	-8.73	-	-	-
Gain (Loss) on Sale of Assets	-0.21	-1.29	23.13	332.27	0.03	-1.7
Asset Writedown	-	-	-	-	-8.5	-
Other Unusual Items	6.25	-	-	-	-	-
Pretax Income	681.05	746.42	1,131	611.18	417.25	610.6
Income Tax Expense	133.78	169.27	213.6	121.43	103.21	112.13
Earnings From Continuing Operations	547.27	577.15	917.49	489.75	314.05	498.48
Minority Interest in Earnings	1.54	0.55	1.6	25.54	30.36	-10.89
Net Income	548.81	577.7	919.08	515.29	344.41	487.59
Preferred Dividends & Other Adjustments	0.87	2.85	45.5	45.5	45.5	1.5
Net Income to Common	547.94	574.84	873.58	469.79	298.91	486.09
Net Income Growth	-18.43%	-37.14%	78.36%	49.62%	-29.37%	-21.15%
Shares Outstanding (Basic)	150	146	134	131	131	119
Shares Outstanding (Diluted)	152	152	151	150	150	132
Shares Change (YoY)	0.17%	0.51%	0.49%	0.11%	14.03%	3.02%
EPS (Basic)	3.64	3.93	6.54	3.58	2.28	4.10
EPS (Diluted)	3.61	3.79	5.79	3.13	1.99	3.76
EPS Growth	-18.35%	-34.54%	84.98%	57.29%	-47.11%	-23.97%
Free Cash Flow	436.18	987.67	1,317	-803.49	730.43	508.83
Free Cash Flow Per Share	2.87	6.51	8.73	-5.35	4.87	3.87
Dividend Per Share	3.600	3.600	4.000	3.000	3.000	3.000
Dividend Growth	-10.00%	-10.00%	33.33%	0%	0%	-14.29%
Gross Margin	17.23%	17.93%	17.11%	12.27%	13.79%	13.58%
Operating Margin	7.38%	7.75%	9.26%	2.33%	4.48%	5.62%
Profit Margin	7.25%	7.46%	8.48%	5.83%	3.52%	4.59%
Free Cash Flow Margin	5.77%	12.81%	12.78%	-9.97%	8.59%	4.80%
EBITDA	674.17	716.01	1,081	330.22	535.61	758.21
EBITDA Margin	8.92%	9.29%	10.49%	4.10%	6.30%	7.16%
D&A For EBITDA	116.22	118.78	127.61	142.36	155.24	162.68
EBIT	557.94	597.23	953.71	187.87	380.37	595.53
EBIT Margin	7.38%	7.75%	9.26%	2.33%	4.48%	5.62%
Effective Tax Rate	19.64%	22.68%	18.88%	19.87%	24.73%	18.36%
Advertising Expenses	-	-	-	360.85	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.